相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NF-κB, Inflammation, and Metabolic Disease
Rebecca G. Baker et al.
CELL METABOLISM (2011)
The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4
Ina Takac et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Jang Hyun Choi et al.
NATURE (2011)
Geniposide inhibits high glucose-induced cell adhesion through the NF-KB signaling pathway in human umbilical vein endothelial cells
Guang-fa Wang et al.
ACTA PHARMACOLOGICA SINICA (2010)
PPARγ regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-κB
Xianghuai Lu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Rosiglitazone Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in a Mouse Model
Rachel E. Nisbet et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
NADPH Oxidases: Functions and Pathologies in the Vasculature
Bernard Lassegue et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Rosiglitazone, thiazolidinediones and atherosclerosis
Paresh Dandona et al.
ATHEROSCLEROSIS (2010)
Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-κB in human aortic smooth muscle cells
Adrian Manea et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase
Garry X. Shen
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
The IDF Diabetes Atlas: Providing evidence, raising awareness and promoting action
Nigel Unwin et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and Type 2 diabetes
S. Neri et al.
EUROPEAN JOURNAL OF NUTRITION (2010)
Quercetin attenuates Monocyte Chemoattractant Protein-1 gene expression in glucose primed aortic endothelial cells through NF-κB and AP-1
Sumith Retnamma Panicker et al.
PHARMACOLOGICAL RESEARCH (2010)
The Framingham Study, Diabetes Mellitus and Cardiovascular Disease: Turning Back the Clock
Andre Pascal Kengne et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension
Sarah F. Knight et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Ling Gao et al.
CARDIOVASCULAR RESEARCH (2009)
Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
Sonal Singh et al.
HEART (2009)
Role of NF-κB in the pathogenesis of diabetes and its associated complications
Sandip Patel et al.
PHARMACOLOGICAL REPORTS (2009)
AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells role of p22phox subunit
Adrian Manea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Peroxisome proliferator activated receptor γ agonists suppress TNFα-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species
Yuyeon Jung et al.
IMMUNOLOGY LETTERS (2008)
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism
Giulio Ceolotto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion
Young-Mi Go et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice
Jinah Hwang et al.
VASCULAR PHARMACOLOGY (2007)
Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes
Alejandra San Martin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction - Results from the PROactive (PROactive 05) study
Erland Erdmann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke - Results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04)
Robert Wilcox et al.
STROKE (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus
Aaron S. Kelly et al.
VASCULAR MEDICINE (2007)
Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes
Christian Rask-Madsen et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
Goodarz Danaei et al.
LANCET (2006)
Cross-talk between nuclear receptors and nuclear factor κB
K. De Bosscher et al.
ONCOGENE (2006)
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques - Effects of rosiglitazone treatment
R Marfella et al.
DIABETES (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
The sources of oxidative stress in the vessel wall
MS Wolin et al.
KIDNEY INTERNATIONAL (2005)
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control
F Pistrosch et al.
DIABETES CARE (2004)
Vascular effects of improving metabolic control with melformin or rosiglitazone in type 2 diabetes
A Natali et al.
DIABETES CARE (2004)
Direct interaction of the novel nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase
RK Ambasta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients
JS Sidhu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
T Inoguchi et al.
DIABETES (2000)
Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells
I Golovchenko et al.
CIRCULATION RESEARCH (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
分享论文
